Exicure XCUR
NASDAQ XCUR
$1.15 -0.15 (-11.54%)
As of: Aug 21, 2026 · 3:59 PM EDT

Exicure (XCUR) Cash from Financing Activities (2016 - 2025)

Exicure's (XCUR) quarterly Cash from Financing Activities came in at $1.6 million in Q1 2025, down 87.1% on a QoQ basis from $12.4 million in Q4 2024.

Exicure (XCUR) Cash from Financing Activities (2016 - 2025) Analysis & Trends

Exicure (XCUR) has 10 years of Cash from Financing Activities data on file, last reported at $1.6 million in Q1 2025.

  • Quarterly Cash from Financing Activities changed N/A year-over-year to $1.6 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (down 88.06% YoY) and the FY2025 annual result came in at $1.6 million, down 88.06% from the prior year.
  • Cash from Financing Activities retreated to $1.6 million in Q1 2025, from $12.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $12.4 million in Q4 2024 to a low of -$8.0 million in Q1 2022.
  • A 5-year average of $1.2 million and a median of $289500.0 in 2021 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 1563.92% — and 2024, when it surged 1240300.0%.
  • Tracing XCUR's Cash from Financing Activities over 5 years: stood at $448000.0 in 2021, then plunged by 100.45% to -$2000.0 in 2022, then jumped by 50.0% to -$1000.0 in 2023, then surged by 1240300.0% to $12.4 million in 2024, then slumped by 87.1% to $1.6 million in 2025.
  • The last three Cash from Financing Activities figures came in at $1.6 million (Q1 2025), $12.4 million (Q4 2024), and $1.0 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 14.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -6.05 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 36.24 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.65 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 27.18 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -273.15 Mn
10 Exicure 7.27 Mn 7.27 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.60 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 12.40 Mn
Dec 31, 2024 12.40 Mn
Jun 30, 2024 1.00 Mn
Jun 30, 2024 1.00 Mn
Dec 31, 2023 -1,000.00
Dec 31, 2023 -1,000.00
Sep 30, 2023 -1,000.00
Sep 30, 2023 -1,000.00
Jun 30, 2023 -919,000.00
Jun 30, 2023 -919,000.00
Mar 31, 2023 4.60 Mn
Mar 31, 2023 4.60 Mn
Sep 30, 2022 -2,000.00
Sep 30, 2022 -2,000.00
Jun 30, 2022 4.89 Mn
Jun 30, 2022 4.89 Mn
Mar 31, 2022 -7.99 Mn
Mar 31, 2022 -7.99 Mn